PURPOSE: The study's objective was to develop diagnostic predictive models using data from two commonly used [(123)I]FP-CIT SPECT assessment methods: region-of-interest (ROI) analysis and whole-brain voxel-based analysis. METHODS: We included retrospectively 80 patients with vascular parkinsonism (VP) and 164 patients with Parkinson's disease (PD) who underwent [(123)I]FP-CIT SPECT. Nuclear-medicine specialists evaluated the scans and calculated bilateral caudate and putamen [(123)I]FP-CIT uptake and asymmetry indices using BRASS software. Statistical parametric mapping (SPM) was used to compare the radioligand uptake between the two diseases at the voxel level. Quantitative data from these two methods, together with potential confounding factors for dopamine transporter availability (sex, age, disease duration and severity), were used to build predictive models following a tenfold cross-validation scheme. The performance of logistic regression (LR), linear discriminant analysis and support vector machine (SVM) algorithms for ROI data, and their penalized versions for SPM data (penalized LR, penalized discriminant analysis and SVM), were assessed. RESULTS: Significant differences were found in the ROI analysis after covariate correction between VP and PD patients in [(123)I]FP-CIT uptake in the more affected side of the putamen and the ipsilateral caudate. Age, disease duration and severity were also found to be informative in feeding the statistical model. SPM localized significant reductions in [(123)I]FP-CIT uptake in PD with respect to VP in two specular clusters comprising areas corresponding to the left and right striatum. The diagnostic predictive accuracy of the LR model using ROI data was 90.3 % and of the SVM model using SPM data was 90.4 %. CONCLUSION: The predictive models built with ROI data and SPM data from [(123)I]FP-CIT SPECT provide great discrimination accuracy between VP and PD. External validation of these methods is necessary to confirm their applicability across centres.
PURPOSE: The study's objective was to develop diagnostic predictive models using data from two commonly used [(123)I]FP-CIT SPECT assessment methods: region-of-interest (ROI) analysis and whole-brain voxel-based analysis. METHODS: We included retrospectively 80 patients with vascular parkinsonism (VP) and 164 patients with Parkinson's disease (PD) who underwent [(123)I]FP-CIT SPECT. Nuclear-medicine specialists evaluated the scans and calculated bilateral caudate and putamen [(123)I]FP-CIT uptake and asymmetry indices using BRASS software. Statistical parametric mapping (SPM) was used to compare the radioligand uptake between the two diseases at the voxel level. Quantitative data from these two methods, together with potential confounding factors for dopamine transporter availability (sex, age, disease duration and severity), were used to build predictive models following a tenfold cross-validation scheme. The performance of logistic regression (LR), linear discriminant analysis and support vector machine (SVM) algorithms for ROI data, and their penalized versions for SPM data (penalized LR, penalized discriminant analysis and SVM), were assessed. RESULTS: Significant differences were found in the ROI analysis after covariate correction between VP and PDpatients in [(123)I]FP-CIT uptake in the more affected side of the putamen and the ipsilateral caudate. Age, disease duration and severity were also found to be informative in feeding the statistical model. SPM localized significant reductions in [(123)I]FP-CIT uptake in PD with respect to VP in two specular clusters comprising areas corresponding to the left and right striatum. The diagnostic predictive accuracy of the LR model using ROI data was 90.3 % and of the SVM model using SPM data was 90.4 %. CONCLUSION: The predictive models built with ROI data and SPM data from [(123)I]FP-CIT SPECT provide great discrimination accuracy between VP and PD. External validation of these methods is necessary to confirm their applicability across centres.
Authors: Georg Goebel; Klaus Seppi; Eveline Donnemiller; Boris Warwitz; Gregor K Wenning; Irene Virgolini; Werner Poewe; Christoph Scherfler Journal: Eur J Nucl Med Mol Imaging Date: 2010-12-21 Impact factor: 9.236
Authors: J Navarro-Otano; C Gaig; A Muxi; F Lomeña; Y Compta; M T Buongiorno; M J Martí; E Tolosa; F Valldeoriola Journal: Parkinsonism Relat Disord Date: 2013-11-05 Impact factor: 4.891
Authors: Michael Nocker; Klaus Seppi; Eveline Donnemiller; Irene Virgolini; Gregor K Wenning; Werner Poewe; Christoph Scherfler Journal: Eur J Nucl Med Mol Imaging Date: 2012-03-30 Impact factor: 9.236
Authors: Sonia Benítez-Rivero; Víctor A Marín-Oyaga; David García-Solís; Ismael Huertas-Fernández; Francisco J García-Gómez; Silvia Jesús; María Teresa Cáceres; Fátima Carrillo; Ana M Ortiz; Manuel Carballo; Pablo Mir Journal: J Neurol Neurosurg Psychiatry Date: 2012-08-20 Impact factor: 10.154
Authors: Willibald Gerschlager; Gerhard Bencsits; Walter Pirker; Bastiaan R Bloem; Susanne Asenbaum; Daniella Prayer; Jan C M Zijlmans; Martha Hoffmann; Thomas Brücke Journal: Mov Disord Date: 2002-05 Impact factor: 10.338
Authors: F J García-Gómez; D García-Solís; F J Luis-Simón; V A Marín-Oyaga; F Carrillo; P Mir; R J Vázquez-Albertino Journal: Rev Esp Med Nucl Imagen Mol Date: 2013-04-06 Impact factor: 1.359
Authors: Sule Tinaz; Christopher Chow; Phillip H Kuo; Elizabeth A Krupinski; Hal Blumenfeld; Elan D Louis; George Zubal Journal: Clin Nucl Med Date: 2018-01 Impact factor: 7.794
Authors: Ismael Huertas; Marianne Oldehinkel; Erik S B van Oort; David Garcia-Solis; Pablo Mir; Christian F Beckmann; Andre F Marquand Journal: Neuroimage Date: 2017-08-04 Impact factor: 6.556
Authors: Ismael Huertas; Silvia Jesús; Francisco Javier García-Gómez; José Antonio Lojo; Inmaculada Bernal-Bernal; Marta Bonilla-Toribio; Juan Francisco Martín-Rodriguez; David García-Solís; Pilar Gómez-Garre; Pablo Mir Journal: PLoS One Date: 2017-04-11 Impact factor: 3.240